Serum paraoxonase: effect of the apolipoprotein composition of HDL and the acute phase response.
about
Apolipoprotein J: A New Predictor and Therapeutic Target in Cardiovascular Disease?Paired measurements of paraoxonase 1 and serum amyloid A as useful disease markersSequence conservation of apolipoprotein A-I affords novel insights into HDL structure-functionHDL apolipoprotein-related peptides in the treatment of atherosclerosis and other inflammatory disordersInfluence of apoA-I and apoE on the formation of serum amyloid A-containing lipoproteins in vivo and in vitroApolipoprotein A-I and serum amyloid A plasma levels are biomarkers of acute painful episodes in patients with sickle cell diseaseParaoxonase enzyme protects retinal pigment epithelium from chlorpyrifos insult.Decreased paraoxonase-1 activity is associated with alterations of high-density lipoprotein particles in chronic liver impairmentEstablishment of a transgenic mouse model specifically expressing human serum amyloid A in adipose tissue.Association of chemerin with oxidative stress, inflammation and classical adipokines in non-diabetic obese patients.Homocysteinethiolactone and paraoxonase: novel markers of diabetic retinopathy.The proteome of sickle cell disease: insights from exploratory proteomic profiling.High Density Lipoprotein and it's DysfunctionThe HDL proteome: a marker--and perhaps mediator--of coronary artery disease.Reduced paraoxonase 1 activity as a marker for severe coronary artery disease.An apoA-I mimetic peptide containing a proline residue has greater in vivo HDL binding and anti-inflammatory ability than the 4F peptideCombined statin and niacin therapy remodels the high-density lipoprotein proteome.Persistence of an atherogenic lipid profile after treatment of acute infection with Brucella.Serum paraoxonase activity and oxidative stress levels in patients with cutaneous anthrax.Serum paraoxonase activity, total thiols levels, and oxidative status in patients with acute brucellosis.Downregulation of human paraoxonase 1 (PON1) by organophosphate pesticides in HepG2 cells.Assessment of low-density lipoprotein oxidation, paraoxonase activity, and arterial distensibility in epileptic children who were treated with anti-epileptic drugs.Distributions of high-density lipoprotein particle components in human follicular fluid and sera and their associations with embryo morphology parameters during IVF.Serum PON1 arylesterase activity in relation to hyperhomocysteinaemia and oxidative stress in young adult central retinal venous occlusion patients.Serum paraoxonase 1 activity in dogs: preanalytical and analytical factors and correlation with C-reactive protein and alpha-2-globulin.PON1 activity and genotype in patients with arterial ischemic stroke and in healthy individuals.Paradoxical effects of SAA on lipoprotein oxidation suggest a new antioxidant function for SAA.Moderate chronic administration of Vineatrol-enriched red wines improves metabolic, oxidative, and inflammatory markers in hamsters fed a high-fat diet.High Density Lipoprotein: Assembly, Structure, Cargo, and Functions
P2860
Q26781196-97E3A36C-4394-4177-8EBA-F1CA41CAC001Q27006749-1D77A232-D2CF-43CC-A8FC-C6CB84877EFAQ27690671-2A8A0E30-6C9A-4C07-A411-D2F42108A0E1Q27691344-D6691138-4447-42E1-9A6D-43CA14E67DFEQ28593885-806A253C-1C03-44DB-AE93-B07EBD59142BQ33551127-93AF1CDC-DB10-4F8B-A049-EAC11675285DQ33825970-6FF9EF71-83B4-4721-8444-25539501C7EAQ33878870-D4A089F2-0F2E-4B04-B9BC-AEB6D2640BCEQ33911023-A23A5CE1-3722-4C85-AEE6-95A70FA28320Q34011460-FB49E096-67BF-48B7-9D4C-B699F8DD68AAQ34084584-52805181-02F9-4ED1-9053-6F3BB31479E0Q34746400-C0DD3B17-AB9C-452F-867B-E8219EB4DAABQ36150462-B8D1B3F0-5DEA-423E-B479-6EBC1D7417FEQ37173205-89238BC9-406C-4E98-B1F4-77AB237343C8Q37176653-E0A68E34-DA0D-4992-8464-16A1A0832C0CQ37299899-90837A77-9D95-4F62-A736-82AF28004397Q37327172-70131BEF-8D70-4315-947B-B49C1370FBE2Q37430645-69C62039-FDDB-4941-8EC5-E4DADDA3EC9EQ40598847-D310AF61-1106-4722-AD40-B1DE60197E70Q41468366-7500310F-05AC-4458-8E50-3838DAC9E660Q42699160-BD656EE3-B687-4AD6-965A-D4A9BCF2AC63Q43046285-C2DDD664-0C50-426E-B6E6-41805BCC2739Q46589935-B130B1EC-D646-489E-A0EF-238D93874E27Q46847172-5D94D432-E1BB-4276-BAF9-3F340F4E6E82Q47781100-345A8D23-8905-4D12-94A2-8998C0E0D4C0Q48128441-DDA60B97-2273-419E-A5C1-ADDDD081F392Q48300156-E3880C91-C464-4630-95F5-7CC471A97AF0Q50478083-81EBC815-0BBC-4D10-B292-6367DB7872F5Q58991979-020DF6A8-9E6C-4F60-96C1-051CD654260F
P2860
Serum paraoxonase: effect of the apolipoprotein composition of HDL and the acute phase response.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Serum paraoxonase: effect of t ...... and the acute phase response.
@en
Serum paraoxonase: effect of t ...... and the acute phase response.
@nl
type
label
Serum paraoxonase: effect of t ...... and the acute phase response.
@en
Serum paraoxonase: effect of t ...... and the acute phase response.
@nl
altLabel
Serum paraoxonase: effect of t ...... L and the acute phase response
@en
prefLabel
Serum paraoxonase: effect of t ...... and the acute phase response.
@en
Serum paraoxonase: effect of t ...... and the acute phase response.
@nl
P2093
P2860
P1476
Serum paraoxonase: effect of t ...... and the acute phase response.
@en
P2093
Catherine A Reardon
Godfrey S Getz
Sean Neath
Veneracion G Cabana
P2860
P304
P356
10.1194/JLR.M200432-JLR200
P407
P577
2003-01-16T00:00:00Z